TIAA-CREF Individual & Institutional Services’s Ligand Pharmaceuticals LGND Stock Holding History

TIAA-CREF Individual & Institutional Services’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$246K	Buy	+787	New	+$233K	﹤0.01%	656

Other funds holding LGND

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

TIAA-CREF Individual & Institutional Services's LGND Position: Q3 2026 in Review

TIAA-CREF Individual & Institutional Services opened a new position in Ligand Pharmaceuticals (LGND) in Q3 2026: 787 shares worth $246K. The stake represents ﹤0.01% of the portfolio and ranks #656 among its holdings.

348 funds tracked by Wall St. Rank hold LGND as of Q3 2026.

TIAA-CREF Individual & Institutional Services held 787 shares of Ligand Pharmaceuticals worth $246K as of Q3 2026.
Ligand Pharmaceuticals was a new TIAA-CREF Individual & Institutional Services position in Q3 2026.
Ligand Pharmaceuticals made up ﹤0.01% of TIAA-CREF Individual & Institutional Services's portfolio in Q3 2026, its #656 holding.
348 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.

Based on TIAA-CREF Individual & Institutional Services's 13F filing for Q3 2026, filed 12 Nov 2026.